Arkansas
On May 10, the Legislature adjourned its fiscal session sine die after adopting a $6.3 billion state budget.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
On May 10, the Legislature adjourned its fiscal session sine die after adopting a $6.3 billion state budget.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
The Department of Health Care Servies posted this alert “Medi-Cal Rx Provider Portal Troubleshooting and Support”. Visit the Medi-Cal Rx Web Portal to see a historical listing of alerts, weekly notices, and monthly bulletins.
Also in California, the Board of Pharmacy posted the May 2024 issue of The Script.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The General Assembly adjourned sine die on May 8.
Also in Colorado, SB24-168, legislation that requires the Department of Health Care Policy and Financing (HCPF) to provide coverage of continuous glucose monitors (CGMs) to Medicaid patients, passed both houses and will be sent to Gov. Jared Polis (D) to sign into law.
Finally in Colorado, HCPF’s Substance Use Disorder Stakeholder newsletter has been posted online.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
The Family and Social Services Administration (FSSA) Office of Medicaid Policy and Planning (OMPP) published the Monthly Medicaid Financial Report webpage to provide transparency and information about expenditure, enrollment, and funding data of the Indiana Medicaid program.
Also in Indiana, the Health Coverage Programs (IHCP) issued updates approved by the Drug Utilization Board in April.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
The Department of Health and Human Services, Iowa Medicaid posted the following:
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Board of Pharmacy’s May newsletter is available online.
Also in Kansas, Gov. Laura Kelly (D) reappointed Erick Axcell, PharmD, and Andy Truong, PharmD, to the Board of Pharmacy for an additional four-year term.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
The Department of Health (LDH) requested the Managed Care Organizations (MCOs) start a new project that will span six months, ending September 30, 2024, requiring each MCO to thoroughly review and make corrections to their network reporting to eliminate inaccurate or outdated information.
Also in Louisiana, the May 14 issue of Pharmacy Facts announced that beginning July 1, 2024, Louisiana Medicaid is revising the Single Preferred Drug List (PDL), shifting both brand and generic versions of these drugs to preferred status. With the implementation of the new PDL, prescribing providers are advised to note “brand name necessary” on prescriptions where they want to ensure pharmacies fill their prescriptions with brand name drugs. Absent this notation, individual pharmacists will make the decision on whether to fill the prescription with brand or generic drugs. The new PDL will be posted online.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
MO HealthNet completed the annual review of the pharmacy preferred drug list and utilization management edits.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
The Board of Pharmacy posted the agenda for its upcoming meeting on May 20.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.